{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:10:39Z","timestamp":1793686239875,"version":"4.5.1"},"reference-count":44,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2024,1,3]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to compare the prevalence and incidence of polyautoimmunity between anticyclic citrullinated peptide antibody (anti-CCP)\u2013positive and anti-CCP\u2013negative patients with rheumatoid arthritis (RA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a nationwide register-based cohort study, patients with RA (disease duration \u2264 2 yrs) in the DANBIO rheumatology register with an available anti-CCP test in the Register of Laboratory Results for Research were identified. The polyautoimmunity outcome included 21 nonrheumatic autoimmune diseases identified by linkage between the Danish Patient Registry and Prescription Registry. The age- and sex-adjusted prevalence ratio (PR) was calculated by modified Poisson regression to estimate the prevalence at diagnosis in anti-CCP\u2013positive vs anti-CCP\u2013negative patients. The hazard ratio (HR) of polyautoimmunity within 5 years of entry into DANBIO was estimated in cause-specific Cox regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 5839 anti-CCP\u2013positive and 3799 anti-CCP\u2013negative patients with RA. At first visit, the prevalence of prespecified polyautoimmune diseases in the Danish registers was 11.1% and 11.9% in anti-CCP\u2013positive and anti-CCP\u2013negative patients, respectively (PR 0.93, 95% CI 0.84-1.05). The most frequent autoimmune diseases were autoimmune thyroid disease, inflammatory bowel disease, and type 1 diabetes mellitus. During a mean follow-up of 3.5 years, only a few (n = 210) patients developed polyautoimmunity (HR 0.6, 95% CI 0.46-0.79).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Polyautoimmunity as captured through the Danish National Patient Registry occurred in approximately 1 in 10 patients with RA at time of diagnosis regardless of anti-CCP status. In the years subsequent to the RA diagnosis, only a few and mainly anti-CCP\u2013negative patients developed autoimmune disease.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.2023-0907","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T13:25:17Z","timestamp":1706793917000},"page":"350-359","source":"Crossref","is-referenced-by-count":2,"title":["Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody\u2013Positive and \u2013Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark"],"prefix":"10.3899","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-5234","authenticated-orcid":false,"given":"Salome","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalie M.","family":"Hagelskj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-2574","authenticated-orcid":false,"given":"Ren\u00e9","family":"Cordtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2456-1019","authenticated-orcid":false,"given":"Sofie","family":"Bliddal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders S.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7543-9016","authenticated-orcid":false,"given":"Claus H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":false,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-8288","authenticated-orcid":false,"given":"Karen B.","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-2922","authenticated-orcid":false,"given":"Lene","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024040105251561000_51.4.350.1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/03009742.2021.1957557","article-title":"Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study","volume":"51","author":"Soussi","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"2024040105251561000_51.4.350.2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1590\/S0482-50042010000500001","article-title":"2010 ACR-EULAR classification criteria for rheumatoid arthritis","volume":"50","author":"Villeneuve","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"2024040105251561000_51.4.350.3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0558-5"},{"key":"2024040105251561000_51.4.350.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.20018"},{"key":"2024040105251561000_51.4.350.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113092"},{"key":"2024040105251561000_51.4.350.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0627-z"},{"key":"2024040105251561000_51.4.350.7","doi-asserted-by":"publisher","DOI":"10.1186\/ar1896"},{"key":"2024040105251561000_51.4.350.8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.berh.2014.10.016","article-title":"Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects","volume":"28","author":"Pratt","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2024040105251561000_51.4.350.9","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02191-2"},{"key":"2024040105251561000_51.4.350.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211782"},{"key":"2024040105251561000_51.4.350.11","doi-asserted-by":"crossref","first-page":"102743","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"Xiao","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2024040105251561000_51.4.350.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.05.002"},{"key":"2024040105251561000_51.4.350.13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2024040105251561000_51.4.350.14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn408"},{"key":"2024040105251561000_51.4.350.15","first-page":"254319","article-title":"Introducing polyautoimmunity: secondary autoimmune diseases no longer exist","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimmune Dis"},{"key":"2024040105251561000_51.4.350.16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/rheumatology\/kez562","article-title":"Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry","volume":"59","author":"Mena-V\u00e1zquez","year":"2020","journal-title":"Rheumatology"},{"key":"2024040105251561000_51.4.350.17","doi-asserted-by":"crossref","first-page":"e183567","DOI":"10.1001\/jamanetworkopen.2018.3567","article-title":"Risk of thyroxine-treated autoimmune thyroid disease associated with disease onset in patients with rheumatoid arthritis","volume":"1","author":"Waldenlind","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2024040105251561000_51.4.350.18","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1093\/rheumatology\/keaa856","article-title":"Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study","volume":"60","author":"Tidblad","year":"2021","journal-title":"Rheumatology"},{"key":"2024040105251561000_51.4.350.19","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/RHU.0000000000001574","article-title":"Frequency of polyautoimmunity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"28","author":"Ordo\u00f1ez-Ca\u00f1izares","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"2024040105251561000_51.4.350.20","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S99490"},{"key":"2024040105251561000_51.4.350.21","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S141438"},{"key":"2024040105251561000_51.4.350.22","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S245060"},{"key":"2024040105251561000_51.4.350.23","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"2024040105251561000_51.4.350.24","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw213"},{"key":"2024040105251561000_51.4.350.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-014-9930-3"},{"key":"2024040105251561000_51.4.350.26","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv193"},{"key":"2024040105251561000_51.4.350.27","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811404278"},{"key":"2024040105251561000_51.4.350.28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12026-014-8598-9","article-title":"Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics","volume":"60","author":"Laz\u00farov\u00e1","year":"2014","journal-title":"Immunol Res"},{"key":"2024040105251561000_51.4.350.29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12020-015-0671-1","article-title":"Increased risk of thyroid autoimmunity in rheumatoid arthritis","volume":"50","author":"Feldt-Rasmussen","year":"2015","journal-title":"Endocrine"},{"key":"2024040105251561000_51.4.350.30","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.12688\/f1000research.11535.1","article-title":"Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity","volume":"6","author":"Bliddal","year":"2017","journal-title":"F1000Res"},{"key":"2024040105251561000_51.4.350.31","doi-asserted-by":"crossref","first-page":"864907","DOI":"10.1155\/2012\/864907","article-title":"Autoimmune thyroid disease in rheumatoid arthritis: a global perspective","volume":"2012","author":"C\u00e1rdenas Rold\u00e1n","year":"2012","journal-title":"Arthritis"},{"key":"2024040105251561000_51.4.350.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203354"},{"key":"2024040105251561000_51.4.350.33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3389\/fimmu.2018.00876","article-title":"Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis","volume":"9","author":"Sieghart","year":"2018","journal-title":"Front Immunol"},{"key":"2024040105251561000_51.4.350.34","doi-asserted-by":"crossref","first-page":"e0195550","DOI":"10.1371\/journal.pone.0195550","article-title":"Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"key":"2024040105251561000_51.4.350.35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/acr.23497","article-title":"Is anti-citrullinated protein antibody-positive rheumatoid arthritis still a more severe disease than anti-citrullinated protein antibody-negative rheumatoid arthritis? A longitudinal cohort study in rheumatoid arthritis patients diagnosed from 2000 onward","volume":"70","author":"Boer","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2024040105251561000_51.4.350.36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/keaa393","article-title":"The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries","volume":"60","author":"Courvoisier","year":"2021","journal-title":"Rheumatology"},{"key":"2024040105251561000_51.4.350.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208873"},{"key":"2024040105251561000_51.4.350.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207326"},{"key":"2024040105251561000_51.4.350.39","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"2024040105251561000_51.4.350.40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-211066"},{"key":"2024040105251561000_51.4.350.41","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024040105251561000_51.4.350.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100488"},{"key":"2024040105251561000_51.4.350.43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2017.00179","article-title":"Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis","volume":"8","author":"Bliddal","year":"2017","journal-title":"Front Endocrinol"},{"key":"2024040105251561000_51.4.350.44","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T12:27:40Z","timestamp":1711974460000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.3899\/jrheum.2023-0907"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0907","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}